VivoSim Labs (FRA:4OR) Total Liabilities : €3.32 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is VivoSim Labs Total Liabilities?

VivoSim Labs's Total Liabilities for the quarter that ended in Dec. 2024 was €3.32 Mil.

VivoSim Labs's quarterly Total Liabilities increased from Jun. 2024 (€2.61 Mil) to Sep. 2024 (€2.77 Mil) and increased from Sep. 2024 (€2.77 Mil) to Dec. 2024 (€3.32 Mil).

VivoSim Labs's annual Total Liabilities increased from Mar. 2022 (€2.80 Mil) to Mar. 2023 (€4.66 Mil) but then declined from Mar. 2023 (€4.66 Mil) to Mar. 2024 (€2.53 Mil).

VivoSim Labs Total Liabilities Historical Data

The historical data trend for VivoSim Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VivoSim Labs Total Liabilities Chart

VivoSim Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

1.64

0.61

2.80

4.66

2.53

VivoSim Labs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															2.48	2.53	2.61	2.77	3.32

VivoSim Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

VivoSim Labs's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.711	+	(0.817	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2.53

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	5.841	-	3.313
	=	2.53

VivoSim Labs's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.805	+	(0.519	+	-0.0010000000000002
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	3.32

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	3.671	-	0.348
	=	3.32

VivoSim Labs Total Liabilities Related Terms

Thank you for viewing the detailed overview of VivoSim Labs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

VivoSim Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VivoSim Labs Inc (FRA:4OR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ONVO:USA 0R02:UK 4OR:Germany

Address

11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

VivoSim Labs Headlines

No Headlines